Bob Kronemyer

8900 N KENDALL DR

Freelance writer for Contemporary OB/GYN

Articles

Novel engineered cytokine plus pembrolizumab to treat ovarian cancer

Heavily pretreated ovarian cancer patients who received a combination therapy of a novel engineered interleukin-2 (IL-2) cytokine plus pembrolizumab achieved an acceptable safety profile, according to a small cohort of an ongoing phase 1/2 trial.

First enhanced recovery after surgery guideline for minimally invasive gynecologic surgery

The first Enhanced Recovery After Surgery (ERAS) guideline for standardizing and optimizing perioperative care for women undergoing minimally invasive gynecologic surgery (MIGS) has been published in The Journal of Minimally Invasive Gynecology.